The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Bruker beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded and GAAP earnings per share increased significantly.
Margins grew across the board.
Bruker booked revenue of $447.8 million. The 13 analysts polled by S&P Capital IQ predicted sales of $421.4 million on the same basis. GAAP reported sales were 7.0% higher than the prior-year quarter's $418.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.28. The 13 earnings estimates compiled by S&P Capital IQ forecast $0.16 per share. GAAP EPS of $0.24 for Q3 were 100% higher than the prior-year quarter's $0.12 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 47.0%, 70 basis points better than the prior-year quarter. Operating margin was 13.5%, 310 basis points better than the prior-year quarter. Net margin was 8.9%, 420 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $485.2 million. On the bottom line, the average EPS estimate is $0.25.
Next year's average estimate for revenue is $1.73 billion. The average EPS estimate is $0.67.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 249 members out of 265 rating the stock outperform, and 16 members rating it underperform. Among 52 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 49 give Bruker a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bruker is outperform, with an average price target of $13.77.
- Add Bruker to My Watchlist.